LogicBio Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
15.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
3
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.24
|
0.00
|
0.24
|
100.00%
|
|
2022-09-30
|
-0.21
|
-0.18
|
0.03
|
14.29%
|
|
2022-06-30
|
-0.24
|
-0.15
|
0.09
|
37.50%
|
|
2022-03-31
|
-0.28
|
-0.20
|
0.08
|
28.57%
|
|
2021-12-31
|
-0.34
|
-0.28
|
0.06
|
17.65%
|
|
2021-09-30
|
-0.30
|
-0.31
|
-0.01
|
-3.33%
|
|
2021-06-30
|
-0.24
|
-0.33
|
-0.09
|
-37.50%
|
|
2021-03-31
|
-0.25
|
-0.32
|
-0.07
|
-28.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-09-30
|
-0.53
|
|
2021-12-31
|
-1.24
|
|
2020-12-31
|
-1.32
|
|
2019-12-31
|
-1.85
|
|
2018-12-31
|
-7.24
|